(Q40422340)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981615%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

title

Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981615%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

1 reference

metabolic dysfunction–associated steatotic liver disease

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981615%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

author name string

Diana Barb

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981615%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Paola Portillo-Sanchez

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981615%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Diane Biernacki

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981615%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Romina Lomonaco

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981615%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Amitabh Suman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981615%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Michelle H Weber

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981615%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Jeffrey T Budd

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981615%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Maria E Lupi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981615%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Kenneth Cusi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981615%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

language of work or name

English

0 references

publication date

25 February 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981615%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981615%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

volume

65

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981615%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981615%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

page(s)

1132-1144

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981615%20AND%20SRC:MED&resulttype=core&format=json

The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

30 March 2020

cites work

1 reference

Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population

21 January 2018

1 reference

Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD.

21 January 2018

1 reference

Clinical value of liver ultrasound for the diagnosis of nonalcoholic fatty liver disease in overweight and obese patients.

21 January 2018

1 reference

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis

21 January 2018

1 reference

Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD

21 January 2018

1 reference

Role of ethnicity in overweight and obese patients with nonalcoholic steatohepatitis.

21 January 2018

1 reference

Plasma thyroid hormone concentration is associated with hepatic triglyceride content in patients with type 2 diabetes.

21 January 2018

1 reference

Relationship of vitamin D with insulin resistance and disease severity in non-alcoholic steatohepatitis

21 January 2018

1 reference

Metabolic Impact of Nonalcoholic Steatohepatitis in Obese Patients With Type 2 Diabetes.

21 January 2018

1 reference

Review of magnetic resonance spectroscopy in the liver and the pancreas

21 January 2018

1 reference

A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes

21 January 2018

1 reference

Endpoints and clinical trial design for nonalcoholic steatohepatitis

21 January 2018

1 reference

Nonalcoholic fatty liver disease: pathologic patterns and biopsy evaluation in clinical research

21 January 2018

1 reference

Association Between Quantity of Liver Fat and Cardiovascular Risk in Patients With Nonalcoholic Fatty Liver Disease Independent of Nonalcoholic Steatohepatitis

21 January 2018

1 reference

Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications

21 January 2018

1 reference

Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites

21 January 2018

1 reference

Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus: A Randomized Trial.

21 January 2018

1 reference

Effect of vildagliptin on hepatic steatosis

21 January 2018

1 reference

Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial)

21 January 2018

1 reference

Effects of Insulin Glargine and Liraglutide Therapy on Liver Fat as Measured by Magnetic Resonance in Patients With Type 2 Diabetes: A Randomized Trial

21 January 2018

1 reference

Response to do ultrasonographic semiquantitative indices predict histological changes in NASH irrespective of steatosis extent?

21 January 2018

1 reference

Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial

21 January 2018

1 reference

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Relationship between disease severity, hyperinsulinemia, and impaired insulin clearance in patients with nonalcoholic steatohepatitis

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/HEP.28985

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981615%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

1 reference